BioSig Technologies, Inc. STEX Common Stock Issued In Settlement Of Accounts Payable And Accrued Expenses
Common Stock Issued In Settlement Of Accounts Payable And Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:CommonStockIssuedInSettlementOfAccountsPayableAndAccruedExpenses.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s common stock issued in settlement of accounts payable and accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s common stock issued in settlement of accounts payable and accrued expenses?
- BioSig Technologies, Inc. (STEX) reported common stock issued in settlement of accounts payable and accrued expenses of $170.75K in Q4 2025.
- How has BioSig Technologies, Inc.'s common stock issued in settlement of accounts payable and accrued expenses changed year-over-year?
- BioSig Technologies, Inc.'s common stock issued in settlement of accounts payable and accrued expenses increased by 459.8% year-over-year, from $30.5K to $170.75K.
- What does common stock issued in settlement of accounts payable and accrued expenses mean?
- Captures the non-cash issuance of common stock to satisfy outstanding accounts payable or accrued expense obligations. This indicates a strategy to preserve cash by utilizing equity as a form of payment for operational liabilities.